Literature DB >> 29117167

Long-range hypoxia signaling in NAFLD.

Edward L LaGory1, Amato J Giaccia1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29117167     DOI： 10.1038/nm.4436

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  Role of ceramides in nonalcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Takhar Kasumov; Arthur J McCullough; Nizar N Zein; John P Kirwan
Journal:  Trends Endocrinol Metab       Date:  2012-05-17       Impact factor: 12.015

2.  Trends in Obesity Among Adults in the United States, 2005 to 2014.

Authors:  Katherine M Flegal; Deanna Kruszon-Moran; Margaret D Carroll; Cheryl D Fryar; Cynthia L Ogden
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

3.  The differential role of Hif1β/Arnt and the hypoxic response in adipose function, fibrosis, and inflammation.

Authors:  Kevin Y Lee; Stephane Gesta; Jeremie Boucher; Xiaohui L Wang; C Ronald Kahn
Journal:  Cell Metab       Date:  2011-10-05       Impact factor: 27.287

4.  Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.

Authors:  Cen Xie; Tomoki Yagai; Yuhong Luo; Xianyi Liang; Tao Chen; Qiong Wang; Dongxue Sun; Jie Zhao; Sadeesh K Ramakrishnan; Lulu Sun; Chunmei Jiang; Xiang Xue; Yuan Tian; Kristopher W Krausz; Andrew D Patterson; Yatrik M Shah; Yue Wu; Changtao Jiang; Frank J Gonzalez
Journal:  Nat Med       Date:  2017-10-09       Impact factor: 53.440

5.  HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling.

Authors:  Sadeesh K Ramakrishnan; Huabing Zhang; Shogo Takahashi; Brook Centofanti; Sarvesh Periyasamy; Kevin Weisz; Zheng Chen; Michael D Uhler; Liangyou Rui; Frank J Gonzalez; Yatrik M Shah
Journal:  Cell Metab       Date:  2016-02-04       Impact factor: 27.287

Review 6.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

Review 7.  Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy.

Authors:  Olga Martínez-Sáez; Pablo Gajate Borau; Teresa Alonso-Gordoa; Javier Molina-Cerrillo; Enrique Grande
Journal:  Crit Rev Oncol Hematol       Date:  2017-01-28       Impact factor: 6.312

8.  Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation.

Authors:  Naomi Hosogai; Atsunori Fukuhara; Kazuya Oshima; Yugo Miyata; Sachiyo Tanaka; Katsumori Segawa; Shigetada Furukawa; Yoshihiro Tochino; Ryutaro Komuro; Morihiro Matsuda; Iichiro Shimomura
Journal:  Diabetes       Date:  2007-04       Impact factor: 9.461

9.  Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.

Authors:  Cullen M Taniguchi; Elizabeth C Finger; Adam J Krieg; Colleen Wu; Anh N Diep; Edward L LaGory; Kevin Wei; Lisa M McGinnis; Jenny Yuan; Calvin J Kuo; Amato J Giaccia
Journal:  Nat Med       Date:  2013-09-15       Impact factor: 53.440

10.  A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition.

Authors:  Kevin Wei; Stephanie M Piecewicz; Lisa M McGinnis; Cullen M Taniguchi; Stanley J Wiegand; Keith Anderson; Carol W-M Chan; Kimberly X Mulligan; David Kuo; Jenny Yuan; Mario Vallon; Lori Morton; Etienne Lefai; M Celeste Simon; Jacquelyn J Maher; Gilles Mithieux; Fabienne Rajas; Justin Annes; Owen P McGuinness; Gavin Thurston; Amato J Giaccia; Calvin J Kuo
Journal:  Nat Med       Date:  2013-09-15       Impact factor: 53.440
View more
  1 in total

1.  Hypoxia-inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36.

Authors:  Esther Rey; Florinda Meléndez-Rodríguez; Patricia Marañón; Miriam Gil-Valle; Almudena G Carrasco; Mar Torres-Capelli; Stephania Chávez; Elvira Del Pozo-Maroto; Javier Rodríguez de Cía; Julián Aragonés; Carmelo García-Monzón; Águeda González-Rodríguez
Journal:  Liver Int       Date:  2020-06-10       Impact factor: 5.828
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.